Sentinel BioTherapeutics is a clinical-stage company developing innovative immune-priming therapies for the treatment of solid tumors Safety data on Sentinel's lead asset to be presented in poster...

AI-Powered Legislative Insights: CODIT's Global Evidence-Based Policy Institute strengthens policy research and strategy SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- CODIT, an AI-powered...

TEN Holdings, Inc. (NASDAQ: XHLD) ("TEN Holdings" or the "Company"), a provider of event planning, production, and broadcasting services, today announced its participation in several...

New software announcements, strategic partnerships, and success stories highlight conference for leading retail technology provider ISELIN, N.J., May 29, 2025 /PRNewswire/ -- Celerant Technology,...

Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based...